PAVmed (PAVM) Inventory Average (2017 - 2024)

PAVmed's (PAVM) quarterly Inventory Average came in at $548500.0 in Q2 2024, up 59.45% quarter-over-quarter from $344000.0 in Q1 2024.

PAVmed (PAVM) Inventory Average (2017 - 2024) Analysis & Trends

PAVmed's Inventory Average history runs 4 years deep, the most recent figure standing at $548500.0 for Q2 2024.

On a quarterly basis, Inventory Average changed N/A year-over-year to $548500.0 in Q2 2024; TTM through Jun 2024 was $548500.0, a N/A change from a year earlier, with the FY2023 full-year figure at $194500.0, changed N/A from the prior year.
Inventory Average improved to $548500.0 in Q2 2024 per PAVM's latest filing, from $344000.0 in the prior quarter.
Across five years, Inventory Average topped out at $548500.0 in Q2 2024 and bottomed at $254000.0 in Q2 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory Avg. (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	6.74 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	5.36 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	6.13 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	3.03 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	1.12 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	661.35 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	3.49 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	2.29 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	2.29 Bn
10	PAVmed	9.85 Mn	-3.35 Mn	-4,000.00	-

Download Data